Kingworld Medicines Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Kingworld Medicines Group heeft een totaal eigen vermogen van CN¥756.7M en een totale schuld van CN¥375.5M, wat de schuld-eigenvermogensverhouding op 49.6% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥1.5B en CN¥754.9M. De EBIT Kingworld Medicines Group is CN¥76.7M waardoor de rentedekking -409.9 is. Het heeft contanten en kortetermijnbeleggingen van CN¥302.1M.
Belangrijke informatie
49.6%
Verhouding schuld/eigen vermogen
CN¥375.46m
Schuld
| Rente dekkingsratio | -409.9x |
| Contant | CN¥302.10m |
| Aandelen | CN¥756.70m |
| Totaal verplichtingen | CN¥754.92m |
| Totaal activa | CN¥1.51b |
Recente financiële gezondheidsupdates
Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04
Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05Recent updates
The Returns On Capital At Kingworld Medicines Group (HKG:1110) Don't Inspire Confidence
Nov 13Kingworld Medicines Group (HKG:1110) Takes On Some Risk With Its Use Of Debt
Oct 04Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0338
May 31Even With A 26% Surge, Cautious Investors Are Not Rewarding Kingworld Medicines Group Limited's (HKG:1110) Performance Completely
May 22Investors Shouldn't Be Too Comfortable With Kingworld Medicines Group's (HKG:1110) Earnings
Apr 29Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0338
Apr 23A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Mar 22The Return Trends At Kingworld Medicines Group (HKG:1110) Look Promising
Nov 30Slowing Rates Of Return At Kingworld Medicines Group (HKG:1110) Leave Little Room For Excitement
Aug 17Kingworld Medicines Group (HKG:1110) Will Pay A Larger Dividend Than Last Year At CN¥0.0247
May 30The Returns At Kingworld Medicines Group (HKG:1110) Aren't Growing
May 11Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To CN¥0.0247
Apr 03Returns On Capital At Kingworld Medicines Group (HKG:1110) Paint A Concerning Picture
Feb 07A Look At The Fair Value Of Kingworld Medicines Group Limited (HKG:1110)
Oct 07Kingworld Medicines Group's (HKG:1110) Returns On Capital Not Reflecting Well On The Business
Jul 05Kingworld Medicines Group (HKG:1110) Is Increasing Its Dividend To HK$0.024
Apr 27We Like These Underlying Return On Capital Trends At Kingworld Medicines Group (HKG:1110)
Aug 17Kingworld Medicines Group (HKG:1110) Seems To Use Debt Rather Sparingly
Apr 24Returns On Capital Are Showing Encouraging Signs At Kingworld Medicines Group (HKG:1110)
Mar 29Kingworld Medicines Group's (HKG:1110) Shareholders Are Down 46% On Their Shares
Mar 08Are Insiders Buying Kingworld Medicines Group Limited (HKG:1110) Stock?
Feb 15Should You Or Shouldn't You: A Dividend Analysis on Kingworld Medicines Group Limited (HKG:1110)
Jan 25
Will the Promising Trends At Kingworld Medicines Group (HKG:1110) Continue?
Dec 18We Think Kingworld Medicines Group (HKG:1110) Can Stay On Top Of Its Debt
Dec 05What We Learned About Kingworld Medicines Group's (HKG:1110) CEO Compensation
Nov 22Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CN¥662.0M ) 1110 } overtreffen de korte termijn passiva ( CN¥574.7M ).
Langlopende schulden: De kortetermijnactiva 1110 ( CN¥662.0M ) overtreffen de langetermijnschulden ( CN¥180.2M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 9.7% ) 1110 wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van 1110 is de afgelopen 5 jaar gestegen van 40.5% naar 49.6%.
Schuldendekking: De schuld van 1110 wordt goed gedekt door de operationele kasstroom ( 31.1% ).
Rentedekking: 1110 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.